Abstract
As radical prostatectomy (RP) remains a commonly used procedure in the treatment of clinically localized prostate cancer, we critically analyzed the evidence suggesting the role of pharmacological prophylaxis and treatment of erectile dysfunction (ED) after surgery. Systematic literature review using Medline and Cancerlit from January 1997 to December 2006. Abstracts published in the journals European Urology, The Journal of Urology, The International Journal of Impotence Research and The Journal of Sexual Medicine as official proceedings of internationally known scientific Societies held in the same time period were also assessed. Patient selection and surgical technique (i.e., preservation of neurovascular bundles) are the major determinants of post-operative erectile function. Pharmacological treatment of post-operative ED, using either oral or local approaches, is effective and safe. Moreover, recent studies have shown that pharmacological prophylaxis early after RP can significantly improve the rate of erectile function recovery after surgery. Use of on-demand treatments for treatment of ED in patients subjected to RP has been shown to be highly effective, especially in case of properly selected young patients treated with a bilateral nerve-sparing approach by experienced surgeons. In this context, pharmacological prophylaxis may potentially have a significant expanding role in future strategies aimed at preserving post-operative erectile function.
Similar content being viewed by others
References
Walsh PC, Donker PJ (1982) Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 128:492–497
Walsh PC, Marschke P, Ricker D, et al (2000) Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology 55:58–61
Walsh PC (2000) Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate. J Urol 163:1802–1807
Rabbani F, Stapleton AM, Kattan MW, et al (2000) Factors predicting recovery of erections after radical prostatectomy. J Urol 164:1929–1934
Stanford JL, Feng Z, Hamilton AS, Gililland FD, et al (2000) Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study. JAMA 283:354–360
Meuleman EJ, Mulders PF (2003) Erectile function after radical prostatectomy: a review. Eur Urol 43:95–101
Montorsi F, Guazzoni G, Strambi LF, et al (1997) Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomised trial. J Urol 158:1408–1410
Brock G, Tu LM, Linet OI (2001) Return of spontaneous erection during long-term intracavernosal alprostadil (Caverject) treatment. Urology 57:536–541
Mulhall J, Land S, Parker M, Waters WB, Flanigan RC (2005) The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. J Sex Med 2:532–545
Raina R, Agarwal A, Ausmundson S, Lakin M, Nandipati KC, Montague DK, Mansour D, Zippe CD (2006) Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potentially earlier return of erectile function. Int J Impot Res 18:77–81
Montorsi F, Maga T, Strambi LF, et al (2000) Sildenafil taken at bedtime significantly increases nocturnal erections: results of a placebo-controlled study. Urology 56:906–911
Behr-Roussel D, Gorny D, Mevel K, Caisey S, Bernabè J, Burgess G, Wayman C, Alexandre L, Giuliano F (2005) Chronic sildenafil improves erectile function and endothelium-dependent cavernosal relaxations in rats: lack of tachyphylaxis. Eur Urol 47:87–91
Padma-Nathan E, McCullough AR, Giuliano F, et al (2003) Postoperative nightly administration of sildenafil citrate significantly improves the return of normal spontaneous erectile function after bilateral nerve-sparing radical prostatectomy. J Urol 4(Suppl):375
Bannowsky A, Schulze H, van der Horst C, Seif C, Braun PM, Junemann KP (2006) Nocturnal tumescence: a parameter for postoperative erectile integrity after nerve sparing radical prostatectomy. J Urol 175:2214–2217
Schwartz EJ, Wong P, Graydon J (2004) Sildenafil preserves intracorporeal smooth muscle after radical retropubis prostatectomy. J Urol 171:771–774
Montorsi F, Salonia A, Gallina A, Zanni G, Saccà A, Dehò F, Briganti A, Grezzi M, Barbieri L, Farina E, Schuit SJ, Rigatti P (2006) There is no significant difference between on-demand PDE5-I vs PDE5-I as rehabilitative treatment in patients treated by bilateral nerve-sparing radical retropubic prostatectomy. In: Proceedings of the meeting of the American Urological Association, Atlanta, 20–25 May
Parsons JK, Marschke P, Maples P, Walsh PC (2004) Effect of methylprednisolone on return of sexual function after nerve-sparing radical retropubic prostatectomy. Urology 64:987–990
Zippe CD, Jhaveri FM, Klein EA, et al (2000) Role of Viagra after radical prostatectomy. Urology 55:241–245
Zagaja GP, Mhoon DA, Aikens JE, Brendler CB (2000) Sildenafil in the treatment of erectile dysfunction after radical prostatectomy. Urology 56:631
Raina R, Lakin MM, Agarwal A, Mascha E, Montagne DK, Klein E, Zippe C (2004) Efficacy and factors associated with successful outcome of sildenafil citrate use for erectile dysfunction after radical prostatectomy. Urology 63:960–966
Raina R, Lakin MM, Agarwal A, Sharma R, Goyal KK, Montague DK (2003) Long-term effect of sildenafil citrate on erectile dysfunction after radical prostatectomy: 3-year follow-up. Urology 62:110–115
Brock G, Nehra A, Lipshultz LI, et al (2003) Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy. J Urol 170:1278–1283
Nehera A, Grantmyre J, Nadel A, Thibonnier M, Brock G (2005) Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy. J Urol 173:2067–2071
Montorsi F, Nathan HP, McCullough A, et al (2004) Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial. J Urol 172:1036–1041
Nehra A, Blute ML, Barrett DM, et al (2002) Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy. Int J Impot Res 14(Suppl 1):S38–S42
Raina R, Agarwal A, Asmundson S, Mansour D, Zippe CD (2005) Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis. Int J Impot Res 17:86–90
Gontero P, Fontana F, Bagnasacco A, et al (2003) Is there an optimal time for intracavernous prostaglandin E1 rehabilitation following nonnerve sparing radical prostatectomy? Results from a hemodynamic prospective study. J Urol 169:2166–2169
Montorsi F, Guazzoni G, Bergamaschi F, et al (1993) Effectiveness and safety of multidrug intracavernous therapy for vasculogenic impotence. Urology 42:554–558
Raina R, Lakin MM, Thukral M, et al (2003) Long-term efficacy and compliance of intracorporeal (ICI) injection for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis. Int J Impot Res 15:318–322
Raina R, Lakin M, Agarwal A, Asmundson S, Montagne D, Zippe CD (2004) Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy. Urology 63:532–538
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Briganti, A., Salonia, A., Gallina, A. et al. Management of erectile dysfunction after radical prostatectomy in 2007. World J Urol 25, 143–148 (2007). https://doi.org/10.1007/s00345-007-0148-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-007-0148-9